Cargando…
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups
SIMPLE SUMMARY: The immunohistochemical analysis of Special AT-rich sequence-binding protein 2 (SATB2) is increasingly being used to detect colorectal differentiation. Our study aimed to investigate SATB2 expression levels and the prognostic relevance of SATB2 loss in colorectal carcinoma (CRC), esp...
Autores principales: | Schmitt, Maxime, Silva, Miguel, Konukiewitz, Björn, Lang, Corinna, Steiger, Katja, Halfter, Kathrin, Engel, Jutta, Jank, Paul, Pfarr, Nicole, Wilhelm, Dirk, Foersch, Sebastian, Denkert, Carsten, Tschurtschenthaler, Markus, Weichert, Wilko, Jesinghaus, Moritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699173/ https://www.ncbi.nlm.nih.gov/pubmed/34944797 http://dx.doi.org/10.3390/cancers13246177 |
Ejemplares similares
-
Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin–eosin-based morphologic parameters from the WHO classification
por: Konukiewitz, Björn, et al.
Publicado: (2021) -
Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?
por: Konukiewitz, Björn, et al.
Publicado: (2021) -
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas—proposal for a new pT3a/pT3b subclassification
por: Foersch, Sebastian, et al.
Publicado: (2022) -
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping
por: Jesinghaus, Moritz, et al.
Publicado: (2017) -
High expression of insulinoma‐associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin
por: Litmeyer, Anne‐Sophie, et al.
Publicado: (2023)